Federal agencies like the US Food and Drug Administration took a major blow to their powers on Friday with a US Supreme Court decision striking down what’s known as the Chevron doctrine, a 40-year-old principle that required courts to defer to regulators when statutory language is ambiguous.
The 6-3 ruling in Loper Bright Enterprises et al. v. Raimondo et al., was divided along ideological lines. The...





